Dyadic International Inc - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH

Ticker Exchange SIC # Website Latest Ticker
DYAI Nasdaq 8731 https://dyadic.com/

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Dyadic International Inc

Dyadic Provides Alternative Proteins Business Update and Announces Attendance at Bioprocess International Conference - Sep 23rd, 2024 1:50 pm
DYAI: Product Revenues Next Year - Aug 19th, 2024 10:21 am
Dyadic Announces Second Quarter 2024 Financial Results and Highlights Recent Company Progress - Aug 13th, 2024 8:05 pm
Dyadic to Report Second Quarter 2024 Financial Results on Tuesday, August 13, 2024 - Jul 30th, 2024 8:00 pm
DYAI: Moo-ve Over Bovines, C1's Taking On Albumin - Jul 1st, 2024 11:24 am
Dyadic International, Inc. and Proliant Health and Biologicals announce Recombinant Albumin Development and Commercialization Partnership - Jun 28th, 2024 12:30 pm
Dyadic to Attend Industry Events in June - May 30th, 2024 8:30 pm
Dyadic International Inc (DYAI) Q1 2024 Earnings Call Transcript Highlights: A Detailed Review ... - May 15th, 2024 9:01 pm
Dyadic Announces First Quarter 2024 Financial Results and Highlights Recent Company Progress - May 14th, 2024 8:00 pm
Dyadic to Attend Industry and Investor Events in May - May 8th, 2024 12:30 pm
Dyadic to Report First Quarter 2024 Financial Results on Tuesday, May 14, 2024 - Apr 30th, 2024 8:30 pm
Dyadic International, Inc. (NASDAQ:DYAI) Q4 2023 Earnings Call Transcript - Apr 1st, 2024 4:24 pm
DYAI: Capital Raise to Accelerate Near Term Revenue Growth - Apr 1st, 2024 12:58 pm
Q4 2023 Dyadic International Inc Earnings Call - Mar 29th, 2024 11:18 am
Dyadic Reports 2023 Full Year Results and Recent Company Progress - Mar 28th, 2024 8:00 pm
Dyadic Announces Change in Board and Management Leadership Roles - Mar 28th, 2024 12:30 pm
Dyadic to Attend Industry Events in April - Mar 27th, 2024 12:30 pm
Dyadic Announces Publication of C1 Monoclonal Antibody in Nonhuman Primate Study in Nature Communications - Mar 26th, 2024 12:30 pm
Dyadic to Attend Future Food Tech Event March 21 – 22, 2024 in San Francisco, California - Mar 21st, 2024 12:30 pm
Dyadic to Report Full Year 2023 Financial Results and Host Conference call on Thursday, March 28, 2024 - Mar 14th, 2024 8:30 pm